These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The effect of phenytoin, phenobarbitone, dexamethasone and flurbiprofen on misonidazole neurotoxicity in mice. Sheldon PW, Clarke C, Dawson KB. Br J Cancer; 1984 Feb; 49(2):207-13. PubMed ID: 6696821 [Abstract] [Full Text] [Related]
24. Effect of cimetidine on the pharmacokinetics of the metabolites of metamizol. Bacracheva N, Tyutyulkova N, Drenska A, Gorantcheva J, Schinzel S, Scholl T, Stoinov A, Tchakarski I, Tentcheva J, Vlahov V. Int J Clin Pharmacol Ther; 1997 Jul; 35(7):275-81. PubMed ID: 9247840 [Abstract] [Full Text] [Related]
28. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats. Akel G, Canal P, Mockey E, Vandevoorde E, Laurent F, Soula G. J Pharmacol; 1983 Aug; 14(1):67-77. PubMed ID: 6834852 [Abstract] [Full Text] [Related]
29. Effects of phenytoin, phenobarbital, and ascorbic acid on misonidazole elimination. Williams K, Begg E, Wade D, O'Shea K. Clin Pharmacol Ther; 1983 Mar; 33(3):314-21. PubMed ID: 6825387 [Abstract] [Full Text] [Related]
32. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines. Mulcahy RT, Siemann DW. Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329 [Abstract] [Full Text] [Related]
33. Time course of phenobarbital and cimetidine mediated changes in hepatic drug metabolism. Døssing M, Pilsgaard H, Rasmussen B, Poulsen HE. Eur J Clin Pharmacol; 1983 Oct; 25(2):215-22. PubMed ID: 6628504 [Abstract] [Full Text] [Related]
34. Inhibition of antipyrine metabolite formation. Steady state studies with cimetidine and metyrapone in rats. Shaw PN, Tseti J, Warburton S, Adedoyin A, Houston JB. Drug Metab Dispos; 1986 Oct; 14(2):271-6. PubMed ID: 2870906 [Abstract] [Full Text] [Related]
35. Pharmacokinetics of hypoxic cell radiosensitizers: a review. Workman P. Cancer Clin Trials; 1980 Oct; 3(3):237-51. PubMed ID: 7438321 [Abstract] [Full Text] [Related]
36. Changes in misonidazole binding with hypoxic fraction in mouse tumors. Hirst DG, Hazlehurst JL, Brown JM. Int J Radiat Oncol Biol Phys; 1985 Jul; 11(7):1349-55. PubMed ID: 4008291 [Abstract] [Full Text] [Related]
37. [Comparative study of the effect of famotidine and cimetidine on antipyrine pharmacokinetics in the human]. Staiger C, Koroknay B, DeVries JX, Weber E, Müller P, Simon B, Dammann HG. Arzneimittelforschung; 1984 Jul; 34(9):1041-2. PubMed ID: 6150717 [Abstract] [Full Text] [Related]
38. Comparative pharmacokinetics, biodistribution, metabolism and hypoxia-dependent uptake of [18F]-EF3 and [18F]-MISO in rodent tumor models. Mahy P, De Bast M, de Groot T, Cheguillaume A, Gillart J, Haustermans K, Labar D, Grégoire V. Radiother Oncol; 2008 Dec; 89(3):353-60. PubMed ID: 18649964 [Abstract] [Full Text] [Related]